Skip to navigation menu Skip to content
High Priority Alert
Informational Alert

Learn about Seattle Children’s Health Equity and Anti-Racism Action Plan, a message from Dr. Jeff Sperring, CEO.

Rajagopal Lab

Welcome to the Rajagopal Lab

In the Rajagopal Lab, we utilize genetic, molecular, biochemical and proteomic approaches to study infectious diseases caused by bacteria. The human pathogens that we study are group B Streptococcus and Staphylococcus aureus. Although both GBS and S. aureus are commensal organisms, these bacteria can also become disease-causing pathogens.

Postdoctoral Fellow Wanted

The Rajagopal Lab is looking for a postdoctoral fellow. Please see our advertisement.

Research Scientist III Wanted

The Rajagopal Lab is looking for a Research Scientist III. Please see our advertisement.

GBS Hemolytic Toxin Research

Rajagopal’s previous GBS research, published in the Journal of Experimental Medicine in 2013, determined the hemolytic toxin found in GBS was not a protein, as previously believed, but a different cell structure known as a lipid. The finding may prevent the development of a vaccine for GBS, because the molecular structure of lipids prevents the toxin from being inactivated by antibodies – the traditional way that vaccines neutralize toxins made of protein molecules. More recently, the group has shown that the GBS hemolytic toxin destroys neutrophils and evades neutrophil extracellular traps in the placenta leading to fetal injury and preterm labor (Sci Immunol 2016;1(4):aah4576).

See also the article and video Study shows how Group B strep foils defenses in pregnancy in the October 2016 issue of UW Health Sciences’ NewsBeat.

Current Research Projects

Current research projects on group B Streptococcus are focused on understanding how the pathogen migrates through different host niches during infections. Research includes identifying the environmental cues/signals that are sensed by the pathogen for regulation of toxins and other virulence factors. Our studies on S. aureus are focused on elucidating factors that regulate antibiotic resistance and virulence of the pathogen. We are also investigating how mutations in host signaling pathways affect disease susceptibility to S. aureus. This is particularly relevant as patients with genetic disorders such as Jobs syndrome and chronic granulomatous disease (CGD) are prone to recurrent and life-threatening infections due to S. aureus.

We hope that a greater understanding of the molecular mechanisms involved during bacterial pathogenesis will enable us to identify novel compounds that can be used to treat these bacterial infections.

Contact Us

Physical Address

Center for Global Infectious Disease Research
307 Westlake Ave. N
Seattle, WA 98109

By clicking “Accept All Cookies,” you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in marketing efforts. For more information, see Website Privacy.

Accept All Cookies